You have 9 free searches left this month | for more free features.

Vaginal Neoplasms

Showing 1 - 25 of 5,446

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rokitansky Kuster Hauser Syndrome, Vaginal Tumors, Gender Incongruence Trial in Amsterdam (Laparoscopic pedicled single flap

Recruiting
  • Rokitansky Kuster Hauser Syndrome
  • +4 more
  • Laparoscopic pedicled single flap peritoneum vaginoplasty
  • Amsterdam, Zuid-Holland, Netherlands
    Amsterdam University Medical Center
Jun 28, 2023

Gynecologic Tumor, Brachytherapy, Therapeutic Touch Trial in Salt Lake City (Reiki therapy)

Not yet recruiting
  • Gynecologic Neoplasm
  • +6 more
  • Reiki therapy
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 9, 2023

Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)

Enrolling by invitation
  • Stage III Vulvar Cancer
  • +7 more
  • Intervention group triads
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Aug 10, 2023

Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (Fit4Treatment)

Not yet recruiting
  • Ovary Cancer
  • +6 more
  • Fit4Treatment
  • Chicago, Illinois
    Northwestern University
Feb 21, 2023

Improvement of Vaginal Health in Breast Cancer, ARISE Study

Recruiting
  • Breast Neoplasms
  • Biospecimen Collection
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 13, 2023

Gynecologic Cancer, Uterus Cancer, Ovary Cancer Trial in Belfast (Mindfulness and exercise, Mindfulness)

Recruiting
  • Gynecologic Cancer
  • +5 more
  • Mindfulness and exercise
  • Mindfulness
  • Belfast, Antrim, United Kingdom
    Ulster University
Sep 29, 2022

Cervical Carcinoma, Malignant Female Reproductive System Tumor, Vaginal Carcinoma Trial in Philadelphia (Perflubutane

Recruiting
  • Cervical Carcinoma
  • +3 more
  • Perflubutane Microbubble
  • Contrast-Enhanced Ultrasound
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jul 5, 2022

Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,

Terminated
  • Recurrent Gynecological Cancer
  • +10 more
  • Boston, Massachusetts
    Martin King
Oct 4, 2022

Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

Not yet recruiting
  • Cervical Cancer
  • +20 more
  • E7 TCR-T cells
  • New Brunswick, New Jersey
  • +1 more
Jan 18, 2023

Cervix Cancer, Vaginal Cancer Trial in Toulouse (Patients with cervix or vaginal cancer treated by radiotherapy and

Completed
  • Cervix Cancer
  • Vaginal Cancer
  • Patients with cervix or vaginal cancer treated by radiotherapy and brachytherapy
  • Toulouse, France
    Institut Universitaire du Cancer de Toulouse - Oncopole
Mar 23, 2022

Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +10 more
  • Discussion
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Mar 24, 2023

Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

Not yet recruiting
  • Ovarian Neoplasms
  • +5 more
  • (no location specified)
Sep 3, 2023

HPV Infection, Vaginal Cancer, Cervical Dysplasia Trial in Orléans (Vaginal Biopsy)

Recruiting
  • HPV Infection
  • +3 more
  • Vaginal Biopsy
  • Orléans, France
    CHR Orléans
Apr 5, 2022

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina Trial in Shanghai (HRYZ-T101 Injection, Fludarabine

Not yet recruiting
  • Cervical Cancer
  • +5 more
  • HRYZ-T101 Injection
  • Fludarabine + Cyclophosphamide
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 17, 2023

Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

Recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Nov 18, 2022

Vaginal Invasion in Cervical Cancer

Not yet recruiting
  • Cervix Carcinoma
  • no intervention
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Sep 11, 2023

Cervical Cancer Trial in London (Fat Graft)

Not yet recruiting
  • Cervical Cancer
  • Fat Graft
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Aug 22, 2023

Retrospective Study of Brachytherapy

Recruiting
  • Brachytherapy
  • +6 more
  • Brachytherapy
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Feb 6, 2022

Endometrial Cancer Trial in Baltimore, Syracuse, Charlottesville (HDR vaginal brachytherapy)

Recruiting
  • Endometrial Cancer
  • HDR vaginal brachytherapy
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

Not yet recruiting
  • HPV-Associated Cervical Carcinoma
  • +16 more
  • Conditioning, E7 TCR-T cells, and aldesleukin
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 17, 2023

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    Cervical Cancer, Uterine Cancer, Vaginal Cancer Trial in Boston (Image-guided brachytherapy, 3'-Deoxy-3'-18f-Fluorothymidine)

    Completed
    • Cervical Cancer
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 8, 2022

    Longitudinal HPV Pap in CIN and VAIN

    Recruiting
    • Cervical Intraepithelial Neoplasia
    • +3 more
    • HPV test and Pap Smear
    • Taoyuan City, Taiwan
      Chang Gung Medical Foundation
    Jun 27, 2023

    Cervical Cancer, Uterine Cancer, Vaginal Cancer Trial in Baltimore (Image-Guided Brachytherapy)

    Recruiting
    • Cervical Cancer
    • +4 more
    • Image-Guided Brachytherapy
    • Baltimore, Maryland
      The SKCCC at Johns Hopkins
    Jan 12, 2022

    Hormone Receptor-positive Breast Cancer Trial (LACUDY)

    Not yet recruiting
    • Hormone Receptor-positive Breast Cancer
    • (no location specified)
    Dec 6, 2022